Literature DB >> 9070356

Ovarian luteal cell toxicity of ethylene glycol monomethyl ether and methoxy acetic acid in vivo and in vitro.

B J Davis1, J L Almekinder, N Flagler, G Travlos, R Wilson, R R Maronpot.   

Abstract

These studies define the site and mechanisms of reproductive toxicity of ethylene glycol monomethyl ether (EGME) in a nongravid female animal model using in vivo and in vitro methods. In vivo studies assessed vaginal cytology and histology, ovarian histology, and serum hormones in 80- to 90-day-old, adult, regularly cycling, female Sprague-Dawley rats treated daily with EGME or vehicle by oral gavage. Dose-response and time-course studies (four to nine rats per group per treatment) determined that 300 mg/kg EGME suppressed cyclicity without systemic toxicity within 3 to 8 days, and doses less than 100 mg/kg had no effect. Pathogenesis studies (six to nine rats per time and treatment) determined that 300 mg/kg EGME elevated serum progesterone within 32 hr after dosing, while serum estradiol, FSH, LH, and prolactin remained at baseline levels. In EGME-treated rats, cyclicity was suppressed, ovulation was inhibited, and corpora lutea were hypertrophied. Thus, EGME appeared to target the ovarian luteal cell. To further examine the toxicity in vitro, luteal cells were recovered from 23-day-old, hCG-primed Sprague-Dawley rats and treated with 0-10 mM methoxy acetic acid (MAA), the proximate toxic metabolite of EGME. MAA (1-10 mM) maintained elevated progesterone levels as production declined in untreated cells at 24 and 48 hr of culture. Progesterone production was maintained independent of LH-stimulated cAMP levels. MAA decreased ATP, but only at 48 hr and at 2.5 mM or greater concentrations. Thus, these studies establish that the ovarian luteal cell is a target of EGME and MAA in vivo and in vitro and that the effect on luteal cell progesterone production is likely independent of LH-stimulated cAMP pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070356     DOI: 10.1006/taap.1996.8035

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Prolonged menstrual cycles in female workers exposed to ethylene glycol ethers in the semiconductor manufacturing industry.

Authors:  G-Y Hsieh; J-D Wang; T-J Cheng; P-C Chen
Journal:  Occup Environ Med       Date:  2005-08       Impact factor: 4.402

Review 2.  Physiological effects and mechanisms of action of endocrine disrupting chemicals that alter estrogen signaling.

Authors:  Derek V Henley; Kenneth S Korach
Journal:  Hormones (Athens)       Date:  2010 Jul-Sep       Impact factor: 2.885

Review 3.  Nonproliferative and proliferative lesions of the rat and mouse female reproductive system.

Authors:  Darlene Dixon; Roger Alison; Ute Bach; Karyn Colman; George L Foley; Johannes H Harleman; Richard Haworth; Ronald Herbert; Anke Heuser; Gerald Long; Michael Mirsky; Karen Regan; Eric Van Esch; F Russell Westwood; Justin Vidal; Midori Yoshida
Journal:  J Toxicol Pathol       Date:  2014       Impact factor: 1.628

4.  Ashwagandha leaf derived withanone protects normal human cells against the toxicity of methoxyacetic acid, a major industrial metabolite.

Authors:  Didik Priyandoko; Tetsuro Ishii; Sunil C Kaul; Renu Wadhwa
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

Review 5.  Luteal toxicity evaluation in rats.

Authors:  Yoshikazu Taketa
Journal:  J Toxicol Pathol       Date:  2021-11-18       Impact factor: 1.628

6.  The short-chain fatty acid methoxyacetic acid disrupts endogenous estrogen receptor-alpha-mediated signaling.

Authors:  Derek V Henley; Stephanie Mueller; Kenneth S Korach
Journal:  Environ Health Perspect       Date:  2009-06-16       Impact factor: 9.031

7.  Ethylene glycol ethers induce oxidative stress in the rat brain.

Authors:  Bartosz Pomierny; Weronika Krzyżanowska; Irena Smaga; Lucyna Pomierny-Chamioło; Piotr Stankowicz; Bogusława Budziszewska
Journal:  Neurotox Res       Date:  2014-08-02       Impact factor: 3.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.